DOI QR코드

DOI QR Code

Scrambler Therapy for Patients with Cancer Pain - Case Series -

  • Park, Hong Sik (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital) ;
  • Sin, Woo Kyung (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital) ;
  • Kim, Hye Young (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital) ;
  • Moon, Jee Youn (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital) ;
  • Park, Soo Young (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital) ;
  • Kim, Yong Chul (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital) ;
  • Lee, Sang Chul (Department of Anesthesiology and Pain Medicine, Seoul National University Hospital)
  • Received : 2012.08.02
  • Accepted : 2012.11.15
  • Published : 2013.01.01

Abstract

More than 80% of cancer patients experience cancer pain. Among them, more than 50% experience moderate to severe pain. To control cancer pain, a variety of methods have been used, including medications and nerve blocks. In some patients, however, it is impossible to perform nerve blocks due to caner metastasis into the epidural space, while in other patients, opioid dose escalation is impossible due to opioid side effects; thus, cancer pain management is difficult. Scrambler therapy is a novel approach for pain control that uses EKG-like pads, which are applied above and below the site of pain. Scrambler therapy synthesizes 16 different types of nerve action potentials that provide "non-pain" information via cutaneous nerves. The advantages of this treatment are that it is non-invasive and safe and has no significant side effects. In this case series, we report the treatment results of using scrambler therapy in three cancer patients with intractable pain.

Keywords

References

  1. Breivik H, Cherny N, Collett B, de Conno F, Filbet M, Foubert AJ, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 2009; 20: 1420-33. https://doi.org/10.1093/annonc/mdp001
  2. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993; 119: 121-6. https://doi.org/10.7326/0003-4819-119-2-199307150-00005
  3. Zenz M, Zenz T, Tryba M, Strumpf M. Severe undertreatment of cancer pain: a 3-year survey of the German situation. J Pain Symptom Manage 1995; 10: 187-91. https://doi.org/10.1016/0885-3924(94)00122-2
  4. Maltoni M. Opioids, pain, and fear. Ann Oncol 2008; 19: 5-7. https://doi.org/10.1093/annonc/mdn008
  5. Li SL, Wang DX, Ma D. Epidural hematoma after neuraxial blockade: a retrospective report from China. Anesth Analg 2010; 111: 1322-4. https://doi.org/10.1213/ANE.0b013e3181f1b9ea
  6. Mertes N, Goeters C, Bantel C, Gullotta F, Van Aken H. Brain death during anesthesia due to undiagnosed meningeal carcinomatosis of gastric adenocarcinoma. Anesthesiology 1999; 90: 630-1. https://doi.org/10.1097/00000542-199902000-00042
  7. Marineo G, Iorno V, Gandini C, Moschini V, Smith TJ. Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial. J Pain Symptom Manage 2012; 43: 87-95. https://doi.org/10.1016/j.jpainsymman.2011.03.015
  8. Smith TJ, Coyne PJ, Parker GL, Dodson P, Ramakrishnan V. Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A $Calmare^{{\circledR}}$) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manage 2010; 40: 883-91. https://doi.org/10.1016/j.jpainsymman.2010.03.022
  9. Marineo G. Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP 2003; 4: 1-10.
  10. Sabato AF, Marineo G, Gatti A. Scrambler therapy. Minerva Anestesiol 2005; 71: 479-82.
  11. de Leon-Casasola OA. Spinal cord and peripheral nerve stimulation techniques for neuropathic pain. J Pain Symptom Manage 2009; 38: S28-38. https://doi.org/10.1016/j.jpainsymman.2009.05.005
  12. Foletti A, Durrer A, Buchser E. Neurostimulation technology for the treatment of chronic pain: a focus on spinal cord stimulation. Expert Rev Med Devices 2007; 4: 201-14. https://doi.org/10.1586/17434440.4.2.201
  13. Jensen MP. A neuropsychological model of pain: research and clinical implications. J Pain 2010; 11: 2-12. https://doi.org/10.1016/j.jpain.2009.05.001
  14. Nathan PW, Wall PD. Treatment of post-herpetic neuralgia by prolonged electric stimulation. Br Med J 1974; 3: 645-7. https://doi.org/10.1136/bmj.3.5932.645
  15. Niv D, Maltsman-Tseikhin A, Lang E. Postherpetic neuralgia: what do we know and where are we heading? Pain Physician 2004; 7: 239-47.
  16. Harke H, Gretenkort P, Ladleif HU, Rahman S. Spinal cord stimulation in sympathetically maintained complex regional pain syndrome type I with severe disability. A prospective clinical study. Eur J Pain 2005; 9: 363-73. https://doi.org/10.1016/j.ejpain.2004.09.003
  17. Harke H, Gretenkort P, Ladleif HU, Koester P, Rahman S. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth Analg 2002; 94: 694-700. https://doi.org/10.1097/00000539-200203000-00040
  18. Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain 2007; 132: 179-88. https://doi.org/10.1016/j.pain.2007.07.028
  19. Mekhail NA, Mathews M, Nageeb F, Guirguis M, Mekhail MN, Cheng J. Retrospective review of 707 cases of spinal cord stimulation: indications and complications. Pain Pract 2011; 11: 148-53. https://doi.org/10.1111/j.1533-2500.2010.00407.x
  20. Ricci M, Pirotti S, Scarpi E, Burgio M, Maltoni M, Sansoni E, et al. Managing chronic pain: results from an open-label study using MC5-A $Calmare^{{\circledR}}$ device. Support Care Cancer 2012; 20: 405-12. https://doi.org/10.1007/s00520-011-1128-6

Cited by

  1. A Trial of Scrambler Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy vol.27, pp.4, 2013, https://doi.org/10.3109/15360288.2013.847519
  2. Treatment of Postherpetic Pain With Scrambler Therapy, a Patient-Specific Neurocutaneous Electrical Stimulation Device pp.1938-2715, 2013, https://doi.org/10.1177/1049909113494002
  3. Oxycodone vol.1492, pp.1, 2014, https://doi.org/10.1007/s40278-014-9441-8
  4. Predictive Factors Associated With Success and Failure for Calmare (Scrambler) Therapy vol.31, pp.8, 2015, https://doi.org/10.1097/AJP.0000000000000155
  5. MC-5A for Complex Regional Pain Syndrome: Case Reports vol.16, pp.7, 2016, https://doi.org/10.1111/papr.12474
  6. Use of Scrambler Therapy in Acute Paediatric Pain: A Case Report and Review of the Literature vol.2016, pp.2090-6811, 2016, https://doi.org/10.1155/2016/2628919
  7. Pilot evaluation of scrambler therapy for pain induced by bone and visceral metastases and refractory to standard therapies vol.24, pp.4, 2016, https://doi.org/10.1007/s00520-015-2952-x
  8. Scrambler Therapy for the management of chronic pain vol.24, pp.6, 2016, https://doi.org/10.1007/s00520-016-3177-3
  9. Recent advances in understanding and managing cancer pain vol.6, pp.2046-1402, 2017, https://doi.org/10.12688/f1000research.10817.1
  10. Scrambler therapy for the treatment of neuropathic pain related to leukemia in a pediatric patient vol.96, pp.45, 2017, https://doi.org/10.1097/MD.0000000000008629
  11. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol vol.19, pp.1, 2018, https://doi.org/10.1186/s13063-018-2874-2
  12. Scrambler therapy efficacy and safety for neuropathic pain correlated with chemotherapy-induced peripheral neuropathy in adolescents: A preliminary study vol.65, pp.7, 2018, https://doi.org/10.1002/pbc.27064
  13. Refractory Pain Management in Amyloid-Associated Peripheral Neuropathy vol.43, pp.4, 2018, https://doi.org/10.1097/AAP.0000000000000733
  14. Scrambler (Calmare) Therapy for Intractable Chronic Pain vol.21, pp.2, 2013, https://doi.org/10.15746/sms.15.039
  15. Efficacy of scrambler therapy on breast cancer-related lymphedema vol.30, pp.11, 2013, https://doi.org/10.1589/jpts.30.1370
  16. Inside the Scrambler Therapy, a Noninvasive Treatment of Chronic Neuropathic and Cancer Pain: From the Gate Control Theory to the Active Principle of Information vol.18, pp.None, 2013, https://doi.org/10.1177/1534735419845143
  17. Innovative Approach for the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Pilot Study With the Hilotherm Device, the Poliambulanza Hospital Experience vol.19, pp.None, 2013, https://doi.org/10.1177/1534735420943287
  18. Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial vol.28, pp.3, 2013, https://doi.org/10.1007/s00520-019-04881-3
  19. Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: State of art and an innovative approach for prevention vol.12, pp.6, 2013, https://doi.org/10.5306/wjco.v12.i6.458
  20. Transcutaneous neurostimulatory treatment for peripheral polyneuropathy induced by hypereosinophilic syndrome - A case report - vol.16, pp.3, 2021, https://doi.org/10.17085/apm.20096